Invesaro

Stocks IZM Financial statements

Financial statements

ICZOOM Group Inc. financial statements

Income statement, balance sheet and cash flow statement for the last 5 fiscal years, taken from the XBRL data ICZOOM Group Inc. files with the SEC in its annual reports.

In USD millions, except per-share amounts. Outflows in the cash flow statement are negative.

Income statement

FY2021FY2023FY2023FY2024FY2025
Revenue290214178187
Cost of revenue283209173181
Gross profit7.815.294.956.11
General and administrative2.512.433.952.96
Operating expenses4.444.426.295.13
Operating income3.370.88-1.340.98
Interest expense0.360.570.70.4
Interest income0.030.010.070.14
Other non-operating income-0.211.14-0.990.51
Pre-tax income3.162.02-2.341.49
Income tax0.590.27-0.070.3
Net income-0.222.571.75-2.271.19
EBITDA3.521.07-1.091.19
EPS, basic0.290.19-0.220.10
EPS, diluted0.270.18-0.200.10
Shares, basic (weighted)8.839.210.411.6
Shares, diluted (weighted)9.559.9211.111.6

Balance sheet

FY2021FY2023FY2023FY2024FY2025
Cash and equivalents6.812.956.415.488.38
Short-term investments0.930
Receivables7676.728.327.2
Inventory0.370.830.341.33
Other current assets2.431.340.981.52
Total current assets88.486.939.140.2
Property, plant and equipment0.120.130.120.06
Lease right-of-use assets0.690.860.380.82
Intangible assets0.380.290.20.13
Other non-current assets0.010.0100.01
Total assets89.688.24041.2
Accounts payable59.651.15.264.28
Deferred revenue3.651.673.042.22
Short-term debt11.81410.2
Total current liabilities78.772.324.625.4
Lease liabilities0.480.380.44
Total liabilities79.172.624.625.8
Paid-in capital14.518.82020.5
Retained earnings-7.09-5.33-7.61-6.41
Other comprehensive income1.04-0.190.65-1.23
Shareholders' equity7.4110.515.515.415.4
Total equity7.4110.515.515.415.4
Total liabilities and equity89.688.24041.2
Shares outstanding8.8310.311

Cash flow statement

FY2021FY2023FY2023FY2024FY2025
Net income-0.222.572-2.271.19
Depreciation and amortization0.150.20.260.21
Stock-based compensation0.051.331.160.61
Deferred income tax0.010.02-0.130.13
Change in receivables-9.21-3.7149.51.21
Change in inventory2.1-0.50.51-0.99
Change in payables5.18-6.36-46.4-0.99
Cash from operations-00.14-3.752.082.75
Capital expenditures-0.02-0.08-0.1-0.03
Purchases of investments-20-4.13-1.12-4.05
Cash from investing0.86-0.14-0.16-0.08
Stock issued4.431.270.11
Cash from financing-3.58.75-2.252.91
Exchange rate effect0-1.36-1.39-0.61-2.69
Net change in cash-0-3.863.46-0.932.89
Free cash flow0.12-3.831.982.71
Interest paid0.360.570.70.4
Income taxes paid0.150.190.150.1

Key metrics

Worked out from the statements above. Latest values use fiscal 2025. Valuation uses the share price of $1.29 on September 25, 2026.

Profitability

MetricValueHow it is calculated
Gross margin3.3%Gross profit / revenue.
Operating margin0.5%Operating income / revenue.
EBITDA margin0.6%EBITDA (operating income + depreciation and amortization) / revenue.
Pre-tax margin0.8%Pre-tax income / revenue.
Net margin0.6%Net income / revenue.
FCF margin1.5%Free cash flow (cash from operations - capital expenditures) / revenue.
Operating cash flow margin1.5%Cash from operations / revenue.
Effective tax rate20.0%Income tax / pre-tax income, when pre-tax income is positive.
Return on equity (ROE)7.8%Net income / average shareholders' equity (opening and closing). Not shown when equity is negative.
Return on assets (ROA)2.9%Net income / average total assets.
Return on invested capital (ROIC)9.3%Approximation: operating income x (1 - tax rate) / average (total debt + equity - cash). Tax rate is the effective rate when between 0% and 50%, else 21%.
Stock-based pay / revenue0.3%Stock-based compensation (from the cash flow statement) / revenue.
Capex / revenue0.0%Capital expenditures / revenue.
D&A / revenue0.1%Depreciation and amortization / revenue.

Growth

MetricValueHow it is calculated
Revenue growth, 1y5.1%Revenue vs the same period a year earlier. Only from a positive base.
Revenue CAGR, 3y-13.6%Compound annual growth of revenue over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Gross profit growth, 1y23.4%Gross profit vs the same period a year earlier. Only from a positive base.
Gross profit CAGR, 3y-7.9%Compound annual growth of gross profit over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Operating income CAGR, 3y-33.7%Compound annual growth of operating income over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
EBITDA CAGR, 3y-30.3%Compound annual growth of ebitda over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Net income CAGR, 3y-22.5%Compound annual growth of net income over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
EPS CAGR, 3y-28.2%Compound annual growth of eps over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Operating cash flow growth, 1y31.9%Operating cash flow vs the same period a year earlier. Only from a positive base.
Operating cash flow CAGR, 3y170.6%Compound annual growth of operating cash flow over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Free cash flow growth, 1y36.7%Free cash flow vs the same period a year earlier. Only from a positive base.
Free cash flow CAGR, 3y185.7%Compound annual growth of free cash flow over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Book value growth, 1y0.3%Book value vs the same period a year earlier. Only from a positive base.
Book value CAGR, 3y13.7%Compound annual growth of book value over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Total assets growth, 1y3.2%Total assets vs the same period a year earlier. Only from a positive base.
Total assets CAGR, 3y-22.8%Compound annual growth of total assets over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Share count change, 1y4.2%Change in diluted weighted shares vs a year earlier. Negative means buybacks shrank the share count; positive means dilution.
Share count change per year, 3y6.6%Change in diluted weighted shares, per year over 3 years. Negative means buybacks shrank the share count; positive means dilution.

Balance sheet health

MetricValueHow it is calculated
Current ratio1.58xCurrent assets / current liabilities.
Quick ratio1.40x(Cash + short-term investments + receivables) / current liabilities.
Cash ratio0.33x(Cash + short-term investments) / current liabilities.
Liabilities / assets62.6%Total liabilities / total assets.
Interest coverage2.48xOperating income / interest expense.
Working capital$14.8MCurrent assets - current liabilities.
Goodwill and intangibles / assets0.3%(Goodwill + intangible assets) / total assets.
Tangible book value$15.3MShareholders' equity - goodwill - intangible assets.

Efficiency

MetricValueHow it is calculated
Asset turnover4.61xRevenue / average total assets.
Fixed asset turnover2,068xRevenue / average property, plant and equipment.
Inventory turnover217xCost of revenue / average inventory.
Days inventory2 days365 x average inventory / cost of revenue.
Receivables turnover6.74xRevenue / average receivables.
Days sales outstanding54 days365 x average receivables / revenue.
Days payables10 days365 x average accounts payable / cost of revenue.
Cash conversion cycle46 daysDays inventory + days sales outstanding - days payables.
FCF conversion227.2%Free cash flow / net income, when net income is positive.
Capex / operating cash flow1.2%Capital expenditures / cash from operations, when that is positive.

Per share

MetricValueHow it is calculated
EPS, diluted$0.10Net income per diluted share, as reported (split-adjusted). Over the last twelve months: the four quarters summed, or net income / latest diluted shares when a quarter has no reported EPS.
EPS, basic$0.10Net income per basic share, as reported (split-adjusted).
Revenue per share$16.19Revenue / diluted weighted shares.
FCF per share$0.23Free cash flow / diluted weighted shares.
Operating cash flow per share$0.24Cash from operations / diluted weighted shares.
Book value per share$1.33Shareholders' equity / shares outstanding (diluted weighted shares when not reported).
Tangible book per share$1.32Tangible book value / shares outstanding.
Cash per share$0.73(Cash + short-term investments) / shares outstanding.

Valuation

MetricValueHow it is calculated
Market cap$15.5MShare price x shares outstanding.
Enterprise value$7.1MMarket cap + total debt - cash - short-term investments.
P/E13.0xMarket cap / net income. Only when net income is positive.
P/S0.08xMarket cap / revenue.
P/B1.01xMarket cap / shareholders' equity. Only when equity is positive.
Price / tangible book1.01xMarket cap / tangible book value, when positive.
P/FCF5.71xMarket cap / free cash flow. Only when free cash flow is positive.
P/OCF5.65xMarket cap / cash from operations, when positive.
EV/Sales0.04xEnterprise value / revenue.
EV/EBIT7.24xEnterprise value / operating income, when both are positive.
EV/EBITDA5.98xEnterprise value / EBITDA, when both are positive.
EV/FCF2.62xEnterprise value / free cash flow, when both are positive.
FCF yield17.5%Free cash flow / market cap.
Earnings yield7.7%Net income / market cap (the inverse of P/E).
What was ICZOOM Group Inc.'s revenue in fiscal 2025?

ICZOOM Group Inc. reported revenue of $187.0M for fiscal 2025, 5.1% higher than the year before.

Was ICZOOM Group Inc. profitable in fiscal 2025?

Yes. Net income was $1.2M, a net margin of 0.6%.

How much free cash flow did ICZOOM Group Inc. generate in fiscal 2025?

Cash from operations of $2.7M minus capital expenditures of $32.5K left free cash flow of $2.7M.

Source: SEC EDGAR XBRL company facts. Where a company tags only year-to-date figures, quarters are worked out as differences. Where a line is not tagged it is left empty, never estimated.

Open interactive statements, quarterly figures and charts

Back to ICZOOM Group Inc.